Spatio-temporal profiling of Filamin A RNA-editing reveals ADAR preferences and high editing levels outside neuronal tissues

RNA Biology

Volumn 10, Issue 10, 2013, Pages 1611-1617

  Stulić, Maja ^a   Jantsch, Michael F ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

ADARs; Adenosine deamination; Development; Filamin A; Mouse; RNA editing

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE DEAMINASES THAT ACT ON RNA 1; ADENOSINE DEAMINASES THAT ACT ON RNA 2; FILAMIN; FILAMIN A; FILAMIN B; MESSENGER RNA; RNA; UNCLASSIFIED DRUG; FLNA PROTEIN, MOUSE;

ANIMAL TISSUE; ARTICLE; BLADDER; BONE; BRAIN CORTEX; BROWN ADIPOSE TISSUE; CARTILAGE; CEREBELLUM; CODING; CONTROLLED STUDY; CROSS LINKING; EMBRYO; ENZYME SPECIFICITY; EYE; FEMALE; GASTROINTESTINAL TRACT; GENE EXPRESSION PROFILING; GENE SEQUENCE; HEART; HIPPOCAMPUS; KIDNEY; KNOCKOUT MOUSE; LARGE INTESTINE; LIVER; LUNG; MOUSE; MUSCLE; NERVOUS TISSUE; NEXT GENERATION SEQUENCING; NONHUMAN; OLFACTORY BULB; PANCREAS; RNA EDITING; SKIN; SMALL INTESTINE; SPINAL CORD; SPLEEN; STOMACH; THALAMUS; WILD TYPE; ANIMAL; ANTIBODY SPECIFICITY; GENETICS; METABOLISM;

MUS;

ADENOSINE DEAMINASE; ANIMALS; FILAMINS; MICE; MICE, KNOCKOUT; ORGAN SPECIFICITY; RNA EDITING; RNA, MESSENGER;

EID: 84886068490     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.26216     Document Type: Article

References (50)

1. Bass BL. RNA editing and hypermutation by adenosine deamination. [published erratum appears in Trends Biochem Sci 1997 Jul;22(7):278]. Trends Biochem Sci 1997;22:157-62; PMID:9175473; http://dx.doi.org/10.1016/S0968-0004 (97) 01035-9
2. Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 2010;79:321-49; PMID: 20192758; http://dx.doi.org/10.1146/ annurev-biochem-060208-105251
3. Bass BL. RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 2002;71:817-46; PMID:12045112; http://dx.doi.org/10.1146/annurev. biochem.71.110601.135501 (Pubitemid 34800236)
4. Riedmann EM, Schopoff S, Hartner JC, Jantsch MF. Specificity of ADAR-mediated RNA editing in newly identified targets. RNA 2008;14:1110-8; PMID:18430892; http://dx.doi.org/10.1261/rna.923308 (Pubitemid 351717491)
5. Wong SK, Sato S, Lazinski DW. Substrate recognition by ADAR1 and ADAR2. RNA 2001;7:846-58; PMID:11421361; http://dx.doi.org/10.1017/S135583820101007X (Pubitemid 32552872)
6. Eggington JM, Greene T, Bass BL. Predicting sites of ADAR editing in double-stranded RNA. Nat Commun 2011;2:319; PMID: 215 8 7 2 3 6; http://dx.doi.org/10.1038/ncomms1324
7. Tariq A, Jantsch MF. Transcript diversification in the nervous system: a to I RNA editing in CNS function and disease development. Front Neurosci 2012;6:99; PMID:22787438; http://dx.doi.org/10.3389/fnins.2012.00099
8. Morabito MV, Abbas AI, Hood JL, Kesterson RA, Jacobs MM, Kump DS, Hachey DL, Roth BL, Emeson RB. Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Neurobiol Dis 2010;39:169-80; PMID: 2 039 4 819; http://dx.doi.org/10.1016/j. nbd.2010.04.004
9. Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, Emeson RB. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 1997;387:303-8; PMID:9153397; http://dx.doi.org/10.1038/387303a0 (Pubitemid 27220768)
10. Kawahara Y, Grimberg A, Teegarden S, Mombereau C, Liu S, Bale TL, Blendy JA, Nishikura K. Dysregulated editing of serotonin 2C receptor mRNAs results in energy dissipation and loss of fat mass. J Neurosci 2008;28:12834-44; PMID:19036977; http://dx.doi.org/10.1523/JNEUROSCI.3896-08.2008
11. Olaghere Da Silva UB, Morabito M V, Canal CE, Airey DC, Emeson RB, Sanders-Bush E. Impact of RNA editing on functions of the serotonin 2C receptor in vivo. Front Neurosci 2010;4:26; PMID:20582266
12. Brusa R, Zimmermann F, Koh DS, Feldmeyer D, Gass P, Seeburg PH, Sprengel R. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 1995;270:1677-80; PMID:7502080; http://dx.doi.org/10.1126/science.270.5242.1677 (Pubitemid 26002446)
13. Maas S, Rich A, Nishikura K. A-to-I RNA editing: recent news and residual mysteries. J Biol Chem 2003;278:1391-4; PMID:12446659; http://dx.doi.org/10. 1074/jbc. R200025200 (Pubitemid 36801360)
14. Yeo J, Goodman RA, Schirle NT, David SS, Beal PA. RNA editing changes the lesion specificity for the DNA repair enzyme NEIL1. Proc Natl Acad Sci U S A 2010;107:20715-9; PMID:21068368; http://dx.doi.org/10.1073/pnas.1009231107
15. Jayan GC, Casey JL. Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression. J Virol 2002;76:12399-404; PMID:12414985; http://dx.doi.org/10.1128/JVI.76.23. 12399-12404.2002 (Pubitemid 35304343)
16. Levanon EY, Eisenberg E, Yelin R, Nemzer S, Hallegger M, Shemesh R, Fligelman ZY, Shoshan A, Pollock SR, Sztybel D, et al. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat Biotechnol 2004;22:1001-5; PMID:15258596; http://dx.doi.org/10.1038/nbt996 (Pubitemid 39014477)
17. Athanasiadis A, Rich A, Maas S. Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol 2004;2:e391; PMID:15534692; http://dx.doi.org/10.1371/journal. pbio.0020391
18. Nishikura K. Editing the message from A to I. Nat Biotechnol 2004;22:962-3; PMID:15286646; http://dx.doi.org/10.1038/nbt0804-962 (Pubitemid 39014471)
19. Horsch M, Seeburg PH, Adler T, Aguilar-Pimentel JA, Becker L, Calzada-Wack J, Garrett L, Götz A, Hans W, Higuchi M, et al. Requirement of the RNA-editing enzyme ADAR2 for normal physiology in mice. J Biol Chem 2011;286:18614-22; PMID:21467037; http://dx.doi.org/10.1074/jbc. M110.200881
20. Wang Q, Miyakoda M, Yang W, Khillan J, Stachura DL, Weiss MJ, Nishikura K. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem 2004;279:4952-61; PMID:14613934; http://dx.doi.org/10.1074/jbc. M310162200 (Pubitemid 38199091)
21. Higuchi M, Maas S, Single FN, Hartner J, Rozov A, Burnashev N, Feldmeyer D, Sprengel R, Seeburg PH. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme A DA R 2. Nature 2000;406:78-81; PMID:10894545; http://dx.doi.org/10.1038/35017558 (Pubitemid 30460214)
22. Hideyama T, Yamashita T, Suzuki T, Tsuji S, Higuchi M, Seeburg PH, Takahashi R, Misawa H, Kwak S. Induced loss of A DA R 2 engenders slow death of motor neurons from Q/R site-unedited GluR2. J Neurosci 2010;30:11917-25; PMID:20826656; http://dx.doi.org/10.1523/JNEUROSCI.2021-10.2010
23. Silberberg G, Lundin D, Navon R, Öhman M. Deregulation of the A-to-I RNA editing mechanism in psychiatric disorders. Hum Mol Genet 2012;21:311-21; PMID:21984433; http://dx.doi.org/10.1093/hmg/ddr461
24. Maas S, Patt S, Schrey M, Rich A. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci U S A 2001;98:14687-92; PMID:11717408; http://dx.doi.org/10.1073/pna s. 251531398 (Pubitemid 33121452)
25. Wahlstedt H, Daniel C, Ensterö M, Ohman M. Large-scale mRNA sequencing determines global regulation of RNA editing during brain development. Genome Res 2009;19:978-86; PMID:19420382; http://dx.doi.org/10.1101/gr.089409. 108
26. Levanon EY, Hallegger M, Kinar Y, Shemesh R, Djinovic-Carugo K, Rechavi G, Jantsch MF, Eisenberg E. Evolutionarily conserved human targets of adenosine to inosine RNA editing. Nucleic Acids Res 2005;33:1162-8; PMID:15731336; http://dx.doi.org/10.1093/nar/gki239 (Pubitemid 41439909)
27. Li JB, Levanon EY, Yoon JK, Aach J, Xie B, Leproust E, Zhang K, Gao Y, Church GM. Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science 2009;324:1210-3; PMID:19478186; http://dx.doi.org/10.1126/science.1170995
28. Feng Y, Walsh CA. The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol 2004;6:1034-8; PMID: 15516996; http://dx.doi.org/10.1038/ncb1104-1034 (Pubitemid 39468003)
29. Hartwig JH, Stossel T P. Isolation and properties of actin, myosin, and a new actinbinding protein in rabbit alveolar macrophages. J Biol Chem 1975;250:5696-705; PMID:124734
30. Nakamura F, Stossel TP, Hartwig JH. The filamins: organizers of cell structure and function. Cell Adh Migr 2011;5:160-9; PMID:21169733; http://dx.doi.org/10.4161/cam.5.2.14401
31. Smith L, Page RC, Xu Z, Kohli E, Litman P, Nix JC, Ithychanda SS, Liu J, Qin J, Misra S, et al. Biochemical basis of the interaction between cystic fibrosis transmembrane conductance regulator and immunoglobulin-like repeats of filamin. J Biol Chem 2010;285:17166-76; PMID:2 0351101; http://dx.doi.org/10. 1074/jbc. M109.080911
32. Wang HY, Burns LH. Naloxone's pentapeptide binding site on filamin A blocks Mu opioid receptor-Gs coupling and CREB activation of acute morphine. PLoS One 2009;4:e4282; PMID:19172190; http://dx.doi.org/10.1371/journal. pone.0004282
33. Jiménez-Baranda S, Gómez-Moutón C, Rojas A, Martínez-Prats L, Mira E, Ana Lacalle R, Valencia A, Dimitrov DS, Viola A, Delgado R, et al. Filamin-A regulates actin-dependent clustering of HIV receptors. Nat Cell Biol 2007;9:838-46; PMID:17572668; http://d x.doi.org/10.1038/ncb1610 (Pubitemid 47019471)
34. Muriel O, Echarri A, Hellriegel C, Pavón DM, Beccari L, Del Pozo MA. Phosphorylated filamin A regulates actin-linked caveolae dynamics. J Cell Sci 2011;124:2763-76; PMID:21807941; http://dx.doi.org/10.1242/jcs.080804
35. Sverdlov M, Shinin V, Place AT, Castellon M, Minshall RD. Filamin A regulates caveolae internalization and trafficking in endothelial cells. Mol Biol Cell 2009;20:4531-40; PMID:19759182; http://dx.doi.org/10.1091/mbc. E08-10-0997
36. Ravid D, Chuderland D, Landsman L, Lavie Y, Reich R, Liscovitch M. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration. Exp Cell Res 2008;314:2762-73; PMID:18598695; http://dx.doi.org/10. 1016/j. yexcr.2008.06.004
37. Head BP, Patel HH, Roth DM, Murray F, Swaney JS, Niesman IR, Farquhar MG, Insel PA. Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J Biol Chem 2006;281:26391-9; PMID:16818493; http://dx.doi.org/10.1074/jbc. M602577200 (Pubitemid 44401847)
38. Hjälm G, MacLeod RJ, Kifor O, Chattopadhyay N, Brown EM. Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase. J Biol Chem 2001;276:34880-7; PMID:11390380; http://dx.doi.org/10.1074/jbc. M100784200
39. Fiori JL, Zhu TN, O'Connell MP, Hoek KS, Indig FE, Frank BP, Morris C, Kole S, Hasskamp J, Elias G, et al. Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells. Endocrinology 2009;150:2551-60; PMID:19213840; http://dx.doi.org/10. 1210/en. 2008-1344
40. Venø MT, Bramsen JB, Bendixen C, Panitz F, Holm IE, Öhman M, Kjems J. Spatio-temporal regulation of ADAR editing during development in porcine neural tissues. RNA Biol 2012;9:1054-65; PMID:22858680; http://dx.doi.org/10.4161/rna.21082
41. Danecek P, Nellåker C, McIntyre RE, Buendia-Buendia JE, Bumpstead S, Ponting CP, Flint J, Durbin R, Keane TM, Adams DJ. High levels of RNA-editing site conservation amongst 15 laboratory mouse strains. Genome Biol 2012;13:26; PMID:22524474; http://dx.doi.org/10.1186/gb-2012-13-4-r26
42. Greenberger S, Levanon EY, Paz-Yaacov N, Barzilai A, Safran M, Osenberg S, Amariglio N, Rechavi G, Eisenberg E. Consistent levels of A-to-I RNA editing across individuals in coding sequences and non-conserved Alu repeats. BMC Genomics 2010;11:608; PMID:21029430; http://dx.doi.org/10.1186/1471-2164-11-608
43. Shtrichman R, Germanguz I, Mandel R, Ziskind A, Nahor I, Safran M, Osenberg S, Sherf O, Rechavi G, Itskovitz-Eldor J. Altered A-to-I RNA editing in human embryogenesis. PLoS One 2012;7:e41576; PMID:22859999; http://dx.doi.org/10.1371/journal.pone.0041576
44. Lehmann KA, Bass BL. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities. Biochemistry 2000;39:12875-84; PMID:11041852; http://dx.doi.org/10.1021/bi001383g
45. Melcher T, Maas S, Herb A, Sprengel R, Seeburg PH, Higuchi M. A mammalian RNA editing enzyme. Nature 1996;379:460-4; PMID:8559253; http://dx.doi.org/10. 1038/379460a0 (Pubitemid 26039528)
46. Jacobs MM, Fogg RL, Emeson RB, Stanwood GD. ADAR1 and ADAR2 expression and editing activity during forebrain development. Dev Neurosci 2009;31:223-37; PMID:19325227; http://dx.doi.org/10.1159/000210185
47. Hartner JC, Schmittwolf C, Kispert A, Müller AM, Higuchi M, Seeburg PH. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem 2004;279:4894-902; PMID: 14 6 15 4 7 9; http://dx.doi.org/10.1074/jbc. M311347200 (Pubitemid 38199085)
48. Garncarz W, Tariq A, Handl C, Pusch O, Jantsch MF. A high-throughput screen to identify enhancers of ADAR-mediated RNA-editing. RNA Biol 2013;10:192-204; PMID:23353575; http://dx.doi.org/10.4161/rna.23208
49. Tariq A, Garncarz W, Handl C, Balik A, Pusch O, Jantsch MF. RNA-interacting proteins act as sitespecific repressors of ADAR2-mediated RNA editing and fluctuate upon neuronal stimulation. Nucleic Acids Res 2013;41:2581-93; PMID:23275536; http://dx.doi.org/10.1093/nar/gks1353
50. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing. EMBnetjournal 2011;17:10-2